Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More
Xconomy
NOVEMBER 11, 2016
—Oral arguments in the landmark patent fight over ownership of the gene editing technology CRISPR-Cas9 were set for Dec. Patent and Trademark Office. —Despite the patent fight, CRISPR work continues apace. —Despite the patent fight, CRISPR work continues apace. billion in yearly sales.
87 
Let's personalize your content